after exposure to environments which produce metabolic change. The analytical approaches to the problem fall into three categories, a) change in effective enzyme activity, b) change in tissue metabolite levels, and c) change in the rate of conversion of one metabolite to another. This report deals with one of the experimental approaches to item c. The labeling patterns observed in rat tissue glutamic acid after administration of pyruvate-2J4C ( 16) or its precursors (5) have been used (2, 5, 12, 16, 17) (2, 17, 27) .
The most dramatic changes in glutamate labeling patterns were observed when glutamic acid isolated from liver protein of fasted rats given pyruvate-2-14C was compared with that isolated from the well-fed animal (5, 16). The protein glutamic acid in the liver of the well-fed animal given pyruvate-2-14C consistently had 30-40 % of its total radioactivity located in C-5. In contrast, liver glutamate from the 48-hr fasted rat had only 2-3 % of its total radioactivity in C-5. These experiments were long term (i.e., the rats were sacrificed several hours after the administration of labeled pyruvate).
Because of the difficulties in interpreting the striking and consistent differences in labeling observed in the fed as compared with the fasted rat, we have conducted three types of experiments; one, the earlier work with rats (16) 
Animal Experiments
Male albino rats were obtained from the Holtzman fed rats; and three, the free glutamic and aspartic acids Company; albino mice from the Department of Microhave been isolated from the livers of fed and fasted rats, biology, Oklahoma State University; guinea pigs and 12 min after the intraperitoneal administration of hamsters from a Stillwater pet shop; rabbits from pyruvate-2-14C, pyruvate-1 -14C or butyrate-1 -14C. These farmers in the area. The labeled compounds were adamino acids were degraded and assayed for radioactivity. ministered by intraperitoneal injection (rabbits I, 2, and The results strongly suggest that the changes in labeling 3, intravenous). Glucagon (2 mg/kg; 1 mg/ml water at pH 2.5 with HCl) was given intraperitoneally to normal fed rats 15 min and 3 hr prior to the injection of isotope. D-Mannoheptulose (600 mg/rat in water) was injected subcutaneously in normal fed rats 1 and 4 hr before injection of the isotope. Cortef acetate (10 mg/day) was given subcutaneously to normal fed rats for 5 days before administration of the isotope. Alloxan monohydrate (100 mg/kg in water) was injected intraperitoneally in 42-hr-fasted rats. The rats were then supplied ad libitum a stock Purina diet and water and sacrificed either 6 days or 4 weeks later. Phloridzin (50 mg/ 100 g as a suspension in water) was injected intraperitoneally 65 min before administration of the isotope; urine sugar analysis with Tes-Tape (Lilly) was strongly positive 5 min after injection and up to sacrifice. Data concerning animal size, treatment, the dose in microcuries and the duration of the experiment after administration of isotope are included in Tables 1, 2 , and 3. The animals were killed by decapitation.
Glutamic acid was isolated from carcass and liver proteins of the long term animals by methods described previously (23). Free glutamic and aspartic acids were isolated (27) from perchloric acid filtrates of livers of the short-term rats. These amino acids, diluted with carrier when necessary, were assayed and degraded by methodology described elsewhere ( 12, 17, 27) .
In some experiments blood samples were collected from a tail vein onto a heparinized slide at various times during the experiment; these samples were deproteinized according to the microtechnique of Somogyi (36) and assayed for glucose.
In some short-term experiments blood was collected at the termination of the experiment in an oxalated beaker and deproteinized by the methods of Somogyi, Shaffer, and Hartman (11). Five milliliters of the deproteinized blood filtrates were passed through Amberlite MB-3 columns (0.8 x 20 cm, in the HC03 form) (7) to remove all ions. The effluents were used to prepare osazones by the method of Steele, Bernstein, and Bjerknes (38) When pyruvate-1 J4C or butyrate-1J4C was given, aspartate was labeled exclusively in C-l and C-4. Whereas pyruvate-1 -14C gave glutamate labeled exclusively in C-1, butyrate-1 -14C gave labeling in C-l and C-5, the ratio being 3 : 1 or 4 : 1. These results are predicted ( 12, 14) . Although the differences may not be significant, fasting increased the specific activity of glutamate when pyruvate-lJ4C was given and decreased it slightly when butyrate-lJ4C was administered (Table  3) . Effect of glucagon. The labeling patterns found in the liver glutamic acid, both 15 min and 3 hr following the injection of glucagon, resemble those found in normal fed rats (Table  2) . E#ect of alloxan, mannoheptulose, and phloridzin.
Glucosuria, as determined by urine tests with Tes-Tape (Lilly) and severe hyperglycemia were used as criteria for the existence of alloxan diabetes. Five days after the administration of alloxan, two of four rats injected showed glucosuria and blood glucose concentrations of greater than 600 mg/lOO ml of blood. The following day fasting markedly diminishes C-5 labeling in liver and carcass glutamate from pyruvate-2J4C in the rabbit, guinea pig, mouse, and hamster (Table  1) . The largest and most consistent changes are in liver. Rabbits and guinea pigs synthesize glutamate with a larger percent of 14C in C-5 than that formed by the other species tested.
Liver Labeling Patterns
The rats were killed 12 min after isotope administration; free glutamic and aspartic acids were isolated from liver (Tables 2, 3) .
Fed and fasted. Labeling patterns (Table  2) in free rat liver glutamate and aspartate 12 min after injection of pyruva te-2J4C are similar to those previously observed (5, 15) and here reported for liver protein glutamate 2 hr after pyruvate administration. Fasting dramatically decreases the labeling in C-5 of glutamate and the carboxyls of aspartate. The specific activity of free liver glutamate is slightly higher in the fasted than the fed rats (data not presented). these two rats were sacrificed, and the blood glucose concentration at death was found to have dropped by fourfold from what it had been the previous day; the percent of labeling in C-5 of liver glutamate from these rats is reduced slightly from that found in a normal control.
The 4-week alloxan diabetic animal, however, had at the termination of the experiment a blood glucose concentration of 478 mg/ 100 ml of blood (Table  2 ) and produced a normal percent of 14C in C-5 of glutamate.
Mannoheptulose administration had a profound effect upon the labeling in glutamate. The percent of 14C found in C-5 was 8-14 % both 1 and 4 hr after its administration (Table  2) . Phloridzin also had a dramatic effect on the percent 14C in C-5 of glutamate, lowering it to about 13 % ( Table  2) .
Efect of glucocorticoids. The single administration of the glucocorticoids, hydrocortisone, and 9-a-fluoroprednisolone for short time periods (data not presented) had no effect on the labeling patterns of glutamate; however, increasing and extendin g the dosage of hydrocortisone to 10 mg/day for a period of 5 days reduced the percent of 14C in C-5 of glutamate to 6 and 13 % ( Table 2) .
Incorporation of Pyruvate-P4C into Blood Glucose
Data on the incorporation of pyruvate-2J4C into blood glucose of fed and fasted rats indicate a tenfold increase in the incorporation of 14C into blood glucose of fasted rats as compared to fed rats (Table  2) . Administering glucagon to a fed rat 15 min before the injection of the isotope increased the amount of incorporation slightly, whereas 3 hr after glucagon treatment the total incorporation of activity into blood glucose resembled that of the normal fed control.
Mannoheptulose, on the other hand, had an immediate as well as a long-lasting effect; the extent of incorporation after 1 hr and after 4 hr was similar and was more than double the total incorporation into blood glucose obtained with glucagon.
Phloridzin treatment resulted in a comparable increase in pyruvate incorporation into blood glucose. Hydrocortisone, given daily for 5 days also increased the total incorporation of pyruvate into blood glucose. Six days after alloxan treatment we noted little effect on the amount of 14C incorporated into blood glucose; however, 4 weeks after alloxan administration, the total incorporation of 14C into blood glucose was more than tripled. In all cases, but that of the 4-week alloxan animal the extent of i4C incorporation into glucose was correlated with the percent of labeling found in C-5 of the liver glutamate; a high amount of 14C incorporation into blood glucose was invariably associated with a low percent labeling of r4C in C-5 of glutamate (Fig. 2) .
Assays In Vitro
Mitochondria isolated from livers of fed rats oxidize pyruvate at a slightly, but significantly, faster rate than 103 (8) 6.4 (2) PARLI ET AL. do those from fasted rats (Table 4) . These results correlate with those obtained in vivo (Tables  1, 2 ).
DISCUSSION
Our studies with different species (Table  1) show clearly that the changes in glutamate labeling patterns with nutritional state are not unique to rats (5, 6, 10, 16) and calves ( 1). Of interest is the very high labeling in C-5 of liver glutamate from fed rabbits and guinea pigs, indicating a somewhat higher percentage conversion of pyruvate to acetyl-CoA than that which occurs in the livers of rats mice, and hamsters.
These longer term experiments with fed and fasted rats are considerably more time consuming than are the shorter term ones which gave parallel results (Table  2) . Clearly, the long-term labeling picture is determined during a very short period after administration of isotope. Thereafter, extensive dilution occurs and little change in the labeling of protein amino acid is possible. The shorter time period is highly recommended because it permits the collection of more data and it makes feasible experiments in which rather rapidly acting control mechanisms are investigated. The crucial question is: do changes in labeling patterns (after giving pyruvate-2 -14C) reflect net changes in pyruvate metabolism or are they merely the result of variations in effective pool sizes (i.e., the flux through a given metabolite).
The following are arguments against the thesis that all or most of the differences observed are due to change in effective pool size (flux) :
If the oxalacetate pool is smaller in the liver of fasted rats, less dilution of labeling in C-Z and C-3 of liver glutamate will occur. This would effect an increased labeling in C-Z and C-3 compared with that in C-5 without a net change in pyruvate metabolism. However, for this mechanism to account for the large decrease in C-5 labeling in fasting, the glutamate isolated from fasted rats would necessarily have at least 10 times the specific activity of that isolated from fed animals. Aspartate should follow a similar pattern. This was not observed; glutamate and aspartate from fasted animals have about twice the specific activity of those from fed animals. These data are in agreement with the proposal that more pyruvate is carboxylated by fasted livers, but do not lend support to the idea that the oxalacetate flux in liver is dramatically decreased in fasting. In fact, all current dogmas suggest the opposite. The observation that the increased incorporation of 14C into blood glucose in fasted rats (Table  Z) , in agreement with the results obtained by others after the administration of 14C-labeled noncarbohydrate precursors (25, 26, 43) and pyruvate-3J4C (7) to fasted rats, leads to the conclusion that the gluconeogenic activity, and hence oxalacetate flux, is increased in fasting animals.
A large increase in the acetyl-CoA flux in fasting liver would cause a dilution of 14C incorporation into C-5 of glutamate (from pyruvate-2-14C). If this is to explain our observation of sharply decreased labeling in C-5, the specific activity of glutamate from fasted rats should be about 30 % less than that of glutamate from fed animals. The reverse was observed. More convincing are the results with butyrate-1 -14C (Table  3) . If the changes observed (fed and fasted, pyruvate-2-14C) were due to tion in varia rats given acetyl-CoA flux, butyrate-lJ4C liver glutama should have tes from much fasted lower specific activities than those of fed animals. In fact, the specific activities are of the same order of magnitude (Table 3) .
Furthermore, if the changes in C-5 labeling observed in the fasted animal were due entirely to an elevated acetyl-CoA flux, the C-4/C-5 ratio should stay constant if the equilibration of pyruvate-2-14C to pyruvate-2-3-14C ( 16) remains unchanged since both C-4 and C-5 of glutamate arise from acetyl-CoA (2, 16). An increase in C-4/C-5 ratio during conditions (in our case, fasting) which diminish C-5 labeling argues against the results being due entirely to dilution by increased acetyl-CoA flux, because this ratio can rise during increased metabolism of pyruvate via oxalacetate (2). Unfortunately, the labeling in C-4 (Table 2) is very low, too low to measure with great accuracy. Thus, although our C-4/C-5 ratios seem to be considerably higher in fasted rats, the errors are too large to permit dogmatic statements. However, it should be emphasized that a constant C-4/C-5 ratio in a situation (i.e., increased gluconeogenesis in fasting) where C-5 labeling decreased, does not argue for a dilution by elevated acetyl-CoA flux because a) in Glutamate C-5 vs. Glucose
In Fig. 2 the percentage of label in C-5 of glutamate is plotted against the 14C incorporation into blood glucose. When one considers the number of variables involved it is apparent that the correlation between C-5 labeling and blood glucose labeling is remarkable.
Only the single 4-week alloxan diabetic animal gave anomalous results. This animal had rather high C-5 labeling and moderate incorporation of 14C into blood glucose. The close correla.-tion shown in Fig. 2 further substantiates the arguments made above in support of the postulate that the percentage labeling in C-5 of liver glutamate is a reflection of net routes of pyruvate metabolism rather than massive changes in effective pool flux.
Mitochondria
Although liver mitochondria from fed rats oxidize pyruvate faster than those from starved animals (Table 4) the differences are too small to account for the great variation observed in glutamate labeling in vivo (Tables  1, 2 ). However, this is not surprising since it is expected that, if pyruvate oxidation is controlled in part by levels of acetyl-CoA or fatty acids ( 19, 39, 41, 44, 48) , a portion of this control would be lost during the isolation of mitochondria.
Thus, these results (Table  4) 
